rovadicitinib   Click here for help

GtoPdb Ligand ID: 12384

Synonyms: example 5 [US10561657B2]
Compound class: Synthetic organic
Comment: This is the chemical structure for the INN rovadicitinib. The structure is claimed in patent US10561657B2, as a Janus kinase (JAK) inhibitor [1]. JAK inhibitors are exploited for immunosuppressive and anti-tumour activities.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 109.2
Molecular weight 321.17
XLogP 2.2
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#CC[C@@H](n1nc(c(c1)c1ncnc2c1cc[nH]2)N)C1CCCC1
Isomeric SMILES C1CCC(C1)[C@@H](CC#N)n1cc(c(n1)N)c1c2cc[nH]c2ncn1
InChI InChI=1S/C17H19N7/c18-7-5-14(11-3-1-2-4-11)24-9-13(16(19)23-24)15-12-6-8-20-17(12)22-10-21-15/h6,8-11,14H,1-5H2,(H2,19,23)(H,20,21,22)/t14-/m1/s1
InChI Key ZGENDZDSLYKCSI-CQSZACIVSA-N
Bioactivity Comments
Example 5 inhibits wild type JAK2, and JAK2 with the activating mutation V617F that is harboured by some cancers [1]. It provides a tumour inhibitory effect in Ba/F3-JAK2V617F tumour-bearing mice.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Janus kinase 2 Hs Inhibitor Inhibition >7.7 pIC50 - 1
pIC50 >7.7 (IC50 <2x10-8 M) [1]
Description: Binned value from patent; inhibition of WT hJAK2